Global type 2 diabetes management news you can trust

What is the latest news concerning Diabetes Type 2 from across the globe? In short: the numbers are still rising, technology is advancing fast, and the world is gearing up for major policy decisions in 2025. At Gluco Journey, we keep our finger on the pulse of global developments so you don’t have to. In this week’s round-up, we bring you the key headlines shaping type 2 diabetes care worldwide — from the World Health Organization’s stark warnings to breakthrough devices, promising research on remission and weight loss treatments, and what all this means for your day-to-day management.

Whether you’re newly diagnosed, living with type 2 diabetes, or supporting someone who is, this guide will help you understand the trends, see where care is heading, and pick up practical steps you can use today. We’ve cited trusted sources throughout, including the World Health Organization (WHO), Glooko’s 2025 diabetes report, and recent diabetes news summaries from WebMD (WHO, WebMD, Glooko: sources linked in References).

If there’s one message from WHO’s latest updates, it’s this: diabetes is growing fast and hitting people earlier. Between 1990 and 2022, adult prevalence doubled to 14%. In 2022, 59% of adults with diabetes were not receiving treatment — and 90% of those untreated people live in low- and middle-income countries. In some regions such as South-East Asia and the Eastern Mediterranean, adult prevalence now hovers around 20%. The result is a heavy toll on lives and health systems, with diabetes and related kidney disease contributing to over 2 million deaths in 2021; almost half of those deaths happened before people reached 70, underscoring the urgent need for earlier diagnosis and better long-term management (WHO: Urgent action needed; WHO: Diabetes fact sheet).

The WHO has been clear about the drivers behind the rise in type 2 diabetes: rising obesity, unhealthy diets, reduced physical activity, and broader economic stresses. In too many places, it’s easier and cheaper to buy energy-dense, nutrient-poor foods than fresh, wholesome options. Aggressive marketing of unhealthy products and limited opportunities for active living make matters worse. These pressures fall hardest on communities with fewer resources, who are already more likely to face barriers accessing healthcare (WHO: Urgent action needed).

The world is taking notice. WHO has launched a global monitoring framework for diabetes. This isn’t just about counting cases — it aims to track prevention efforts, blood sugar control, blood pressure management, and real access to essential care. The idea is to help countries measure progress, learn from what works, and close gaps faster. Importantly, the framework highlights not only clinical measures, but also the systems and policies that make healthier living more achievable (WHO: Urgent action needed).

One of the biggest tech stories of the past year is the expansion of automated insulin delivery (AID) into type 2 diabetes. In August 2024, the US FDA approved a device enabling automated insulin delivery for people with type 2. While availability will vary by country, this marks a turning point: it recognises that many people with type 2 can benefit from smarter insulin support, not only those with type 1. For those who are insulin-treated and meet eligibility criteria, AID systems can reduce the day-to-day burden of adjusting doses and watching glucose, freeing up energy for life beyond diabetes (WebMD Diabetes News; Glooko 2025 Diabetes Report).

Dietary programmes continue to show promise. A UK programme using a strict low-calorie diet achieved diabetes remission in around one-third of participants. That’s a hopeful signal that, with the right support, some people can reduce their blood sugar to non-diabetes levels without medication for a time. However, experts stress this approach isn’t for everyone: it must be carefully planned, medically supervised, and tailored to individual health needs to be safe and effective. If you’re considering a significant dietary change, speak with your healthcare team first (WebMD Diabetes News).

The biggest challenge running through all the latest news is inequity. WHO reports that in 2022, nearly 6 in 10 adults with diabetes were untreated, and 9 in 10 of these untreated adults live in low- and middle-income countries. Technology, too, is unevenly distributed: while some countries are scaling CGMs and remote care, others struggle to provide essential medicines consistently. This isn’t just a resource issue; it’s a structural one, shaped by supply chains, training, policy, and pricing (WHO: Urgent action needed; WHO: Diabetes fact sheet; Glooko 2025 Diabetes Report).

WHO and other authorities emphasise the basics because they work. Across countries and health systems, the most reliable path to prevention and better control includes:

• A healthy, balanced diet rich in vegetables, whole grains, beans and lentils, lean proteins, and healthy fats.
• Regular physical activity, aiming for consistency over perfection.
• Maintaining a healthy weight, or reducing weight gradually if recommended by your clinician.
• Avoiding tobacco.
• Ensuring fair access to screening and essential medications (WHO: Urgent action needed; WHO: Diabetes fact sheet).

If you’re new to diabetes technology, the choices can feel overwhelming. Here’s a simple path:

• Start with awareness: learn how your current meals and routines affect your numbers. Even without a CGM, structured checks can reveal valuable patterns.
• Add a CGM if available to you: the real-time feedback can help you fine-tune portion sizes, meal timing, and activity. Look at trends, not single numbers.
• Consider advanced systems if appropriate: for those on insulin, discuss whether automated insulin delivery could reduce the daily mental load and improve stability.
• Keep it human: technology is powerful, but it works best with coaching and clinical guidance — people who can help you make sense of the data and choose actions that feel doable.

Policy momentum: The UN High-level Meeting on NCDs in 2025 is poised to drive commitments that could improve access to essential diabetes screening and care, strengthen primary care systems, and support prevention measures across countries. WHO’s global monitoring framework will help track progress and keep accountability high (WHO: Urgent action needed).

Gluco Journey exists to turn the latest diabetes insights into everyday wins for you. Here’s how we can support you right now:

• Personalised coaching: friendly, practical guidance tailored to your culture, preferences and daily routines.
• Data-informed care: from simple tracking to full CGM support, we help you make sense of numbers and choose next steps that fit your life.
• Weight and nutrition support: strategies for steady, sustainable weight change, including meal planning, label reading, and budget-friendly recipes.
• Tech onboarding: practical help choosing, setting up and using diabetes devices, including CGMs and, where appropriate, automated insulin delivery systems.
• Prevention and screening: reminders and education about key checks, from blood pressure and kidney health to eye and foot care.
• Equity focus: accessible options that work even if you don’t have advanced devices; because everyone deserves high-quality support.